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Although genomewide scans have identified several potential chromosomal susceptibility regions in several human
populations, finding a causative gene for type 2 diabetes has remained elusive. Others have reported a novel gene,
calpain-10 (CAPN10), located in a previously identified region on chromosome 2q37.3, as a putative susceptibility
gene for type 2 diabetes. Three single-nucleotide polymorphisms (SNPs) (UCSNP43, UCSNP19, and UCSNP63)
were shown to be involved in increased risk of the disease amongMexican Americans. We have tested the association
of these three SNPs with type 2 diabetes among the Samoans of Polynesia, who have a very high prevalence of
the disease. In the U.S. territory of American Samoa, prevalence is 25% and 15% in men and women, respectively,
whereas, in the independent nation of Samoa, prevalence is 3% and 5% in men and women, respectively. In our
study sample, which consisted of 172 unrelated affected case subjects and 96 control subjects, we failed to detect
any association between case subjects and control subjects in allele frequencies, haplotype frequencies, or haplotype
combinations of UCSNP43, -19, and -63. Also, our data showed no evidence of linkage, among 201 affected sib
pairs, in the region of chromosome 2 that contains these SNPs. Three plausible scenarios could explain these
observations. (1) CAPN10 is a susceptibility gene only in particular ethnic groups; (2) our study lacks power to
detect the effects of CAPN10 polymorphisms (but our sample size is comparable to that of earlier reports); or (3)
the underlying biological mechanism is too complex and requires further research.
Introduction
Non–insulin-dependent diabetes mellitus (NIDDM), also
called “type 2 diabetes” (MIM 125853), is a common
disease that affects ∼135 million people on a global scale
(King et al. 1998). Substantial evidence has been presented
that type 2 diabetes has a complex genetic etiology, and,
in recent years, genomewide scans have identified several
potential chromosomal susceptibility regions (e.g., Hanis
et al. 1996; Mahtani et al. 1996; Hanson et al. 1998;
Elbein et al. 1999; Ghosh et al. 1999; Hegele et al. 1999;
Ehm et al. 2000; Watanabe et al. 2000; Permutt et al.
2001). Nevertheless, finding a causative gene has re-
mained elusive. Hanis et al. (1996) reported linkage to a
region on chromosome 2q37.3 among Mexican Ameri-
cans and identified a major susceptibility locus (NIDDM1
[MIM 601283]), located in the interval that spans mark-
ers D2S125–D2S140. Following a combined strategy of
positional cloning and a newly developed statistical
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method of partitioning linkage, these investigators iden-
tified a novel gene, calpain-10 (CAPN10 [MIM 605286]),
as a putative type 2 diabetes susceptibility gene in this
region (Horikawa et al. 2000). Three single-nucleotide
polymorphisms (SNPs) (UCSNP43, UCSNP19, and
UCSNP63), all located in intronic sequences, were found
to be involved in increased risk of the disease. Although
the common G allele at SNP43 (henceforth, the SNPs are
abbreviated without the prefix “UC”) was initially found
to be significantly associated with the phenotype in fam-
ilies that showed linkage to NIDDM1 on chromosome
2, haplotype 112/121 (defined by the three SNP sites) had
shown the highest risk, an almost threefold risk of de-
veloping diabetes.
In the present study, we tested the association of the
three polymorphisms (SNP43, 19, and 63) at the
CAPN10 gene with type 2 diabetes among the Samoans
of the western Pacific. The Samoan participants are dis-
tributed over two polities, the independent nation of
Samoa (formerly Western Samoa) and the U.S. territory
of American Samoa. Samoa is a relatively underdevel-
oped country with a largely agricultural economy. Ap-
proximately 15% of the adults are engaged in wage
earning, and the remainder are involved in local sub-
sistence farming and fishing. On the other hand, Amer-
ican Samoa has received substantial financial support
from the U.S. federal government since the 1950s; the
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economy is far less agricultural than that of Samoa, with
∼60% of males and ∼42% of women in the labor force
(U.S. Department of Commerce 1990). In spite of great
economic disparity between the two polities and ex-
posure to different levels of the processes of moderni-
zation, they form one sociocultural unit, with the fre-
quent exchange of mates and the maintenance of
extended familial relationships across the border. We
also note that our earlier population genetic studies
demonstrated no genetic difference between the two lo-
cales (Deka et al. 1994). The contemporary adult Sa-
moan population has a very high prevalence of over-
weight, obesity, and type 2 diabetes (McGarvey and
Baker 1979; Zimmet 1979; McGarvey 1991, 1993; Col-
lins et al. 1994; Hodge et al. 1994). The prevalence and
four-year incidence rates of type 2 diabetes (defined as
fasting glucose levels 1126 mg/dl) are significantly
higher in American Samoan men and women 29–62
years of age than in their Samoan counterparts. In
American Samoa, prevalence is 25% and 15% in men
and women, respectively, compared with 3.3% and
5.4% in men and women, respectively, from Samoa.
Four-year incidence, measured from 1990–1991 to
1994–1995, is 12.4% and 8.5% in American Samoan
men and women, respectively, compared with 2% and
2.6% in men and women, respectively, from Samoa
(McGarvey et al. 2000; S. T. McGarvey, unpublished
data). It is reasonable to conceive that the differences
in diabetes prevalence in Samoa and American Samoa
largely reflect an interaction between genetic suscepti-
bility and environmental and lifestyle factors—in this
instance, differential exposure to the processes of
modernization.
Methods
Subjects
Affected subjects.—A sample of 299 affected sib pairs
and 1 half-sib pair from 371 individuals in 176 families
was recruited in American Samoa, using the Department
of Health diabetes registry. The diagnosis of type 2 di-
abetes was confirmed by medical records. It should be
noted that the registry also includes case subjects who
were considered to have type 1 diabetes and were there-
fore excluded from the present study. Mean age of the
371 case subjects was years, with a range55.0 11.5
of 30–80 years. Age at onset of type 2 diabetes was
calculated on the basis of the individual’s self-report of
the number of years since diagnosis. The mean age at
onset of type 2 diabetes was years, with a47.6 10.7
range of 30–75 years. Extensive medical histories were
collected, with a focus on information about how and
when the subjects’ type 2 diabetes was diagnosed. The
interview included items about diabetes medication and
use of injected insulin. We selected the first affected sib
identified in each family to form the unrelated case sub-
jects ( ). The first affected sib in each family wasNp 172
our proband from the diabetes registry through whom
the family initially came to our attention. Subjects were
asked about their Samoan ancestry, to limit study par-
ticipation to those who reported that all four grand par-
ents were of Samoan ethnicity without European or
Asian ancestry. Study protocols were approved by the
institutional review board of the Miriam Hospital, Prov-
idence, RI. Written informed consent was obtained from
all participants.
Control subjects.—We established a control sample of
96 individuals who did not have type 2 diabetes; 40 were
recruited from American Samoa, and 56 were recruited
from Samoa. These samples were derived from our ear-
lier longitudinal studies of adiposity and risk factors for
cardiovascular disease in American Samoa and Samoa
in 1990–1995 (McGarvey et al. 1993; Galanis et al.
1999). The control subjects were 50 years of age and
had fasting glucose levels of !120 mg/dl and body mass
indexes !30 kg/m2. These two measures were below
these levels at both of two consecutive time points, four
years apart, of data collection in our earlier longitudinal
studies.
Genotyping
Genomic DNA was extracted from buffy coats, using
Puregene DNA isolation kit (Gentra Systems), according
to standard protocols. Primer sequences and protocols
for PCR amplification and analysis of SNP43, -19, and
-63 were kindly provided by Drs. Nancy J. Cox and
Craig L. Hanis. In brief, 10–20 ng of genomic DNA
were amplified in a total volume of 10 ml of reaction
mixture containing standard PCR buffer, 10 pmol of
each primer, 200 mm of each dNTP, and 0.5 U of Taq
DNA polymerase. For SNP43 and -63, the amplified
products were digested with restriction enzymesNsiI and
HhaI, respectively. The products were separated by elec-
trophoresis on 2% agarose gel.
The genome scan was conducted using the ABI 10-
cM panel of microsatellite markers, according to stan-
dard protocols, on an ABI 377 automated DNA se-
quencer (Applied Biosystems). A negative control sample
and two positive control samples of known genotype
(CEPH sample 1347-02) were tested, as a quality con-
trol, on each gel. Genescan 672 software was used to
collect the data, to track lanes, to estimate fragment
sizes, and to check internal size standards. Genotypes
were assigned using the Genotyper software.
Statistical Analyses
Relationship testing and error checking.—We used the
programs Relpair (version 0.9) and Prest to check the
accuracy of relationships between individuals within
families without removing genotyping errors from the
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original data (Boehnke and Cox 1997; McPeek and Sun
2000). These analyses were based on 125 markers typed
throughout the genome. Relpair implements a likeli-
hood-based method to infer the most likely relationship
for each pair. It applies a hidden-Markov–model algo-
rithm to calculate the identity-by-descent (IBD) distri-
bution of each pair. Then, under the assumption of no
genetic interference, it estimates the multipoint likeli-
hood of the marker data for each pair and infers the
most likely relationship between each pair. Because Rel-
pair estimates the likelihood conditional only on each
of four possible relationships (full sibs, monozygotic
twins, half sibs, and unrelated pairs), we then checked
the more distant relationships, such as avuncular and
first-cousin relationships, by using the program Prest.
Instead of using a hidden-Markov method, Prest uses an
augmented IBD Markov process to calculate the likeli-
hood of the marker data. There are two new test sta-
tistics, conditional expected IBD (EIBD) and adjusted
identity-by-state (AIBS), in Prest. We initially screened
the data by use of these two statistics and then performed
the maximum-likelihood–ratio test (MLRT) in Prest to
infer the most likely relationship for each pair. The pro-
gram PedCheck was used to identify the genotyping er-
rors in the data (O’Connell and Weeks 1998).
Allele frequencies.—Allele frequencies for each SNP
in the control subjects and the unrelated case subjects
were computed by gene counting. We then tested, by use
of a 2 # 2 contingency x2 test, whether there was a
significant difference in allele frequencies between the
control group recruited from American Samoa and that
from Samoa, as well as between the control subjects and
the unrelated case subjects. Conformity of genotype pro-
portions to Hardy-Weinberg expectations was tested by
using the program Gen (Lazzeroni and Lange 1998).
Haplotype estimation.—Haplotype frequencies were
estimated by the programs EH, Zaplo, and Phase (Xie
and Ott 1993; Terwilliger and Ott 1994; O’Connell
2000; Stephens et al. 2001). All three programs imple-
ment the expectation-maximization (EM) algorithm to
estimate haplotype frequencies. The EH program uses
the method of gene counting, which provides maximum-
likelihood estimates of the haplotype frequencies. Both
EH and Phase are applicable only to unrelated individ-
uals. In contrast, Zaplo uses a pedigree-based likelihood
method to estimate haplotype frequencies and can there-
fore be applied to the intact family structures, using all
individuals in the family. Under the assumption of no
recombination between the markers, the initial step is
to compute the likelihood of the marker data by as-
signing equal allele frequencies for each haplotype. Zap-
lo then computes the expected haplotype frequencies by
using the probability of each genotype to weight the
counts, and the program updates the likelihood by use
of the expected values. It then iterates until convergence.
Because our unrelated case subjects are drawn from fam-
ilies that contain multiple affected siblings, it is impor-
tant to use Zaplo to verify that the haplotype frequencies
obtained using all members of the families are very sim-
ilar to the frequencies obtained when one affected case
subject was selected from each family. This is especially
relevant, since our set of families contains more-precise
information about haplotype frequencies than does our
subset of singleton unrelated case subjects.
Test of linkage disequilibrium.—Linkage disequilib-
rium (LD) was evaluated by the program GOLD for each
pairwise comparison of the SNPs in the case subjects
and the control subjects (Abecasis and Cookson 2000).
We calculated the standardized disequilibrium coeffi-
cient D′ and the D2 measure of disequilibrium, as de-
scribed for each pair of the SNPs. The association of
each pairwise comparison was tested by Fisher’s exact
test (Hedrick 1987; Devlin and Risch 1995).
Association analyses.—We used a nonparametric T5
statistic, which is implemented in the EH program, to
test whether haplotype frequencies were significantly dif-
ferent between the familial case subjects and the control
subjects (Zhao et al. 2000). To compute T5, we ran EH
three times—on the case subjects alone, on the control
subjects alone, and on the combination of case subjects
and controls—to obtain the following three log-likeli-
hoods: lnLcase, lnLcontrol, and lnLcombined. Under the hy-
pothesis that the allelic association was allowed, we
computed the T5 statistic, which is defined as 2[ln(Lcase)
 ln(Lcontrol)  ln(Lcombined)], which has an approximate
x2 distribution, to test the association of haplotype fre-
quencies between the case subjects and the control
subjects.
Besides testing for association on the basis of haplo-
type frequencies, we also examined the association be-
tween specific haplotype combinations and type 2 dia-
betes. We used the program Phase, which deploys a
Bayesian approach, to estimate the most likely haplo-
types of the three SNPs in the case subjects and the
control subjects separately. In the first step, Phase esti-
mates the haplotype frequencies, using the EM algorithm
from 100 different starting points, and then chooses the
estimate of haplotype frequencies with the highest like-
lihood. Next, it uses these haplotype frequencies as a
priori expectations, performs Gibbs sampling to obtain
an approximate sample from the posterior distribution
of haplotypes given genotypes, and then chooses the
most probable haplotype assignment for each individual.
Linkage analyses.—Nonparametric linkage analyses of
30 microsatellite markers (ABI panels 3 and 4) spanning
chromosome 2 were performed using the program Al-
legro (Gudbjartsson et al. 2000). We calculated multi-
point Sall LOD scores under the linear model.
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Table 1
Estimated Allele Frequencies for SNP43, -19, and -63 in the 40
American Samoa Control Subjects and the 56 Samoan Control
Subjects
SNPa
ALLELE 1 FREQUENCY
(NO./TOTAL) INb
x2 PAS Controls S Controls
43 .897 (70/78) .920 (103/112) .073 .788
19 .375 (30/80) .366 (41/112) .001 .980
63 .821 (64/78) .848 (95/112) .095 .758
a We used the allele labeling scheme of Horikawa et al. (2000), in
which allele 1 at SNP43 is the G allele, allele 1 at SNP19 is the two
repeats of the 32-bp sequence, and allele 1 at SNP63 is the C allele.
b AS p American Samoan; S p Samoan.
Table 2
Estimated Allele Frequencies for SNP43, -19, and -63 in the 172
Case Subjects (Typed at One or More SNPs) and the 96 Control
Subjects
SNP
ALLELE 1 FREQUENCY
(NO./TOTAL) IN
x2 PCases Controls
43 .914 (309/338) .911 (173/190) .0003 .986
19 .326 (107/328) .370 (71/192) .837 .360
63 .853 (273/320) .837 (159/190) .135 .714
Results
Our relationship testing, which was based on 125 mark-
ers typed throughout the genome, revealed that the spec-
ified relationships of the members within some families
were inconsistent with the relationships inferred from
the marker data. Thus, we omitted all the pedigrees with
unresolved structures and generated a conservative data
set consisting of 139 families containing 201 affected sib
pairs and 1 half-sib pair. This data set was used for
subsequent analyses that depend on pedigree structure
(i.e., Zaplo and the multipoint LOD scores). However,
the majority of the association analyses presented here
are not affected by uncertain pedigree structures, since
they are based only on the proband from each family.
In this context, it should be noted that there are no
differences in sociodemographic characteristics or dia-
betes status between the group of probands identified
from the diabetes registry and the group of probands’
siblings. For example, the ratio of women to men among
the probands is 50:50, and that among the siblings is
45:55. Among women, the mean age of the proband is
53.4 years and that of other siblings is 53.3 years.
Among men, the mean age of the proband is 57.5 years
and that of other siblings is 55.7 years. The average
length of time since diagnosis among women is 7.0 years
and 6.5 years for probands and other siblings, respec-
tively; and, among men, average length of time since
diagnosis is 8.3 years and 7.7 years for probands and
other siblings, respectively. More than 85% of the pro-
bands currently use diabetic medication, compared with
83% of the other siblings. There is no apparent bias in
sex, age, or diabetes severity in choosing the proband
(first sibling recruited) in each family for the genetic
analyses.
Allele Frequencies
Tests for genetic homogeneity in the allele frequencies
of SNP43, -19, and -63 between the American Samoan
and Samoan control subjects showed no significant dif-
ference in the allele frequencies at each of the three poly-
morphic sites between these two control groups (table
1). Our earlier population genetic study also had dem-
onstrated that there is no difference in allele frequencies
at nine hypervariable and four serum protein loci be-
tween these two geographical groups of Samoans (Deka
et al. 1994). Hence, we combined the control subjects
from both places to form one control group, which was
used in the further analyses. We then compared the allele
frequencies between the familial case subjects (the pro-
bands) and the control subjects. The results showed that
there was no significant difference in the allele frequen-
cies of SNP43, -19, and -63 between the familial case
subjects and the control subjects (table 2). Also, the ge-
notype frequencies of all the SNPs that we used were in
Hardy-Weinberg equilibrium (data not shown).
Analyses of Association
We were interested in testing whether the haplotype
frequencies of SNP43, -19, and -63 were different be-
tween the case subjects and the control subjects. Table
3 presents the haplotype frequencies in 151 case subjects,
94 control subjects, and all the siblings for whom data
at all of the three polymorphisms are available. Six of
the eight possible haplotypes were observed in the total
data set. The three most common haplotypes were 121,
111, and 112 (allele designations are shown in table 1).
The haplotype frequencies estimated by each program
(EH, Zaplo, and Phase) were quite consistent (table 3).
Also, the haplotype frequencies estimated on the basis
of the family data were very close to the results estimated
on the basis of the unrelated subjects. We then tested
whether the haplotype frequencies of SNP43, -19, and
-63 were significantly different between the familial case
subjects and the control subjects. The results indicated
that there was no evidence of association between the
familial case subjects and the control subjects (Pp
) (table 4)..858
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Table 3
Estimated Haplotype Frequencies in the 151 Case Subjects and 94 Control Subjects, When Individuals Are Included Only If They Are
Typed at All Three SNPs
HAPLOTYPE
FREQUENCY IN
ALL SUBJECTS IN CASE
FAMILIES, AS DETERMINED
BY ZAPLO
CASE SUBJECTS,
AS DETERMINED BY
CONTROL SUBJECTS,
AS DETERMINED BY
SNP43 SNP19 SNP63 EH Zaplo Phase EH Zaplo Phase
1 1 1 .196 .187 .185 .185 .221 .225 .218
1 1 2 .117 .141 .136 .142 .146 .144 .149
1 2 1 .586 .581 .585 .579 .523 .522 .527
1 2 2 .000 .005 .007 .007 .019 .019 .016
2 1 1 .000 .000 .000 .000 .000 .000 .000
2 1 2 .000 .000 .000 .000 .000 .000 .000
2 2 1 .095 .086 .083 .086 .090 .089 .090
2 2 2 .006 .003 .004 .000 .000 .000 .000
Table 4
Association Testing Based on the Haplotype Frequencies of SNP43,
-19, and -63 between the Case Subjects and the Control Subjects
Group N ln(L) x2 Pa
Case 151 281.97 69.44 .858
Control 94 190.35 33.87
Combination 245 473.96 101.04
a Calculated from the T5 statistic: 2[ln(L)case  ln(L)control  ln(L)case
 control]; .dfp 7
Haplotype Combination and the Risk of Type 2
Diabetes
We also calculated the odds ratio (OR) for each hap-
lotype combination relative to all the other haplotype
combinations as a group, to test if there was association
between the different haplotype combinations and the
risk of type 2 diabetes. There was no significant differ-
ence in any haplotype combination of SNP43, -19, and
-63 between the case subjects and the control subjects
(table 5).
Evaluation of LD
Pairwise LD between each pair of SNPs was measured
on the basis of the case subjects and the control subjects
separately. We performed Fisher’s exact test to check LD
between each pair of SNPs. LD was observed between
SNP43 and SNP19 and between SNP43 and SNP63,
both in the case subjects and in the control subjects (table
6).
Multipoint Linkage Analysis
Multipoint linkage analysis in 139 families in the con-
servative data set for 30 microsatellite markers (ABI pan-
els 3 and 4) indicated that there was no promising peak
across chromosome 2 that could be linked to type 2
diabetes. The maximum nonparametric LOD score,
which was only 0.40, occurred near D2S286, whereas
the LOD score curve was 0 in the region (between
D2S125 [at 260.6 cM from pter] and D2S140 [at 263.6
cM from pter]) that contained the three SNPs (data not
shown).
American Samoan Control Subjects
Using only the American Samoan control subjects, we
repeated all the analyses presented in tables 1–6, and
obtained qualitatively similar results (data not shown)
that do not alter any of the conclusions presented here.
Discussion
The findings of Horikawa et al. (2000) were unexpected,
given that calpains are cysteine proteases and are un-
likely to be involved in the pathways of glucose ho-
meostasis. In a commentary, Permutt et al. (2000) noted
that the connection between calpain-10 and glucose me-
tabolism is far from clear. Nonetheless, the finding that
CAPN10 was a putative type 2 diabetes susceptibility
gene was significant, because it represented the first gene
associated with a common and complex disease to be
identified by positional cloning. However, validation of
these findings in other populations is needed to establish
the role of calpain-10 polymorphisms in susceptibility
to type 2 diabetes. In a follow-up study among the Pima
Indians, it was found that, although homozygosity for
the G allele at SNP43 was not associated with a higher
prevalence of type 2 diabetes, homozygosity was asso-
ciated with reduced calpain-10 mRNA levels in muscle
cells and with decreased rates of glucose turnover that
were suggestive of insulin resistance (Baier et al. 2000).
Since then, several studies conducted in various human
populations have been reported in abstract form, and
they present conflicting evidence of association. In a
Finnish population from Botnia, the SNP43 G allele was
shown to be associated with insulin resistance and type
2 diabetes (Orho-Melander et al. 2000). In two other
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Table 5
Association between the Haplotype Combinations and
Type 2 Diabetes
Haplotype
Combination
No. of
Cases
No. of
Controls OR (95% CI)
111/111 5 3 1.04 (.24–4.45)
111/112 9 7 .79 (.28–2.19)
111/121 31 23 .80 (.43–1.47)
112/112 3 2 .93 (.15–5.69)
112/121 26 12 1.42 (.68–2.98)
112/122 0 2 …
121/121 50 28 1.17 (.67–2.04)
121/122 1 1 .62 (.04–10.03)
221/221 0 1 …
221/111 6 5 .74 (.22–2.48)
221/112 2 3 .41 (.07–2.48)
221/121 17 7 1.58 (.63–3.96)
221/122 1 0 …
Total 151 94 …
Table 6
Pairwise Linkage Disequilibrium between SNP43, -19, and -63 in
the 151 Case Subjects and the 94 Control Subjects
PAIRWISE
COMPARISON
CASESa CONTROLSa
Pb D′ D2 Pb D′ D2
SNP43 vs. SNP19 .000 1.000 .214 .000 1.000 .240
SNP43 vs. SNP63 .020 1.000 .128 .080 1.000 .140
SNP19 vs. SNP63 .000 .934 .560 .000 .847 .494
a D′p standardized disequilibrium coefficient measurement; D2p
measure of disequilibrium.
b By Fisher’s exact test.
samples of white populations (German and Czech), as-
sociation between type 2 diabetes and calpain-10 poly-
morphisms was indicated (Schwarz et al. 2001). How-
ever, no association was found in a Polish population
(Malecki et al. 2001) or in a Chinese population (Ng et
al. 2001). In a recently published large study of white
populations in Britain and Ireland, Evans et al. (2001)
did not find any association, either individually or as
haplotypes, with the three SNPs considered here. How-
ever, one of the alleles, allele C, at a fourth locus in the
CAPN10 gene, SNP44, was found to be preferentially
transmitted to affected children in parent-offspring trios,
and these affected individuals had an excess of this allele
when compared with population control subjects. Al-
though this finding is interesting, it needs further eval-
uation, in view of the fact that this association was not
observed in a second case-control group or in a set of
discordant sibs. The affected offspring in the trios rep-
resented a group of individuals who were, on average,
younger and more obese than the other diabetic pro-
bands in the study. The question thus arises whether
SNP44 is associated with a smaller subset of patients
with earlier-onset type 2 diabetes, distinct from that
found in the typical late-onset type 2 diabetes phenotype.
Furthermore, it should be noted that Evans et al. (2001)
found no evidence of linkage at the CAPN10 locus.
In the Samoan populations that we studied, we failed
to detect any association between case subjects and con-
trol subjects in allele frequencies, haplotype frequencies,
or haplotype combinations of SNP43, -19, and -63.
Also, our data showed no evidence of linkage in the
region of chromosome 2 that contains these SNPs. The
Samoans represent a relatively small isolated population
that has been subjected to population bottlenecks and
genetic drift, so we are not surprised to find that genetic
variation in SNP43, -19, and -63 among this group is
different from that in other populations. Allele fre-
quencies of these three SNPs in Samoans are more sim-
ilar to those in Asians than to those in Mexican Amer-
icans, Europeans, or Amerindians (Horikawa et al.
2000). Haplotype frequencies in Samoans are different
from Mexican Americans, Europeans, Asians, and Am-
erindians. Therefore, one must consider the effects of
genetic and population heterogeneity when attempting
to detect susceptibility genes for type 2 diabetes in dif-
ferent populations. Although we also found that the
112/121 haplotype combination appears to increase the
risk of type 2 diabetes in Samoans, the OR is not sig-
nificant ( , 95% confidence intervalORp 1.42 [CI]p
) (table 5). The 121/221 haplotype combi-0.68–2.98
nation has an even higher OR, but the OR is also not
significant ( , ). TheseORp 1.58 95%CIp 0.63–3.96
findings, together with observations from other world-
wide populations noted above, raise the question of
whether CAPN10 is a diabetes susceptibility gene only
in some particular ethnic groups. It is likely that evo-
lutionary histories of individual populations have an
important role in disease susceptibility loci of complex
traits in which the susceptibility alleles have minor in-
dividual effects. Thus, the contribution of alleles at a
specific locus to type 2 diabetes susceptibility will be
likely to vary across different populations. It should be
noted that the Samoans have a significantly reduced
level of genetic variation when compared with large
cosmopolitan populations (Deka et al. 1994). It is not
unlikely that in this population, some alleles have be-
come enriched at the expense of others because of ge-
netic drift and related evolutionary forces. One likely
scenario is that the calpain-10 polymorphisms are true
functional variants; however, they interact with other
genetic polymorphisms, whose individual effects on dis-
ease susceptibility could have been altered by differences
in allele frequency among various populations. Such
differences might result from the differing evolutionary
histories of the populations, as noted above, or could
even arise from the interaction of the calpain-10 poly-
morphisms with variable environmental exposures. As
a result of such varied gene-gene or gene-environment
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interactions, the effect of a functional variant could vary
between populations, thereby leading to variation in
disease susceptibility. In fact, Horikawa et al. (2000)
had noted that the risk of disease could be modified by
other polymorphisms located in and around the func-
tional variants, which affect the transcriptional activity
of the CAPN10 gene. The risk may also be modified by
haplotypic effects created by alleles at loci that are in
LD with the functional variants (Evans et al. 2001). The
ability to detect associations also depends on muta-
tional, allele, and haplotype frequencies. Thus, it is not
surprising that there have been a variety of positive and
negative findings regarding CAPN10 and its association
with type 2 diabetes.
Our lack of significant results is unlikely to have re-
sulted from low power, because the number of families
in our study (176) is comparable to that (170) in the
original study by Horikawa et al. (2000). Horikawa et
al. (2000) observed an OR of 2.80 for the 112/121
haplotype combination in 170 Mexican American fam-
ilies and an OR of 3.58 in their second set of 69 Mexican
American families. Given our sample sizes, we have
180% power to detect an OR of 2.80 at the significance
level of .025, and we have 190% power to detect an
OR of 3.58 at the significance level of .010. Thus, if
the 112/121 haplotype combination had an effect in the
Samoan population similar to that seen in the Mexican
American population, we would have had relatively
high power to detect it. Even so, the possibility remains
that our results may be consistent with those reported
by Horikawa et al. (2000), because our OR of 1.42 is
within the 95% CI of their populations, except for that
of the second set of Mexican Americans. However, we
note that our OR may not be strictly comparable, be-
cause some of the previous studies selected control sub-
jects at random, whereas we used older nonobese non-
diabetic individuals as control subjects.
Another plausible explanation for apparently contra-
dictory findings across studies is that the underlying
biological mechanism of the CAPN10 gene is complex
and its functional relevance and physiological roles in
glucose metabolism are yet to be understood. In the
discussion above, we have noted the findings of Baier
et al. (2000), which are initial steps in determining the
functional role of the CAPN10 gene. However, a more
recent study contradicts these implications. In a study
of 74 nondiabetic German subjects, Stumvoll et al.
(2001) found that the G allele at SNP43 was associated
with higher glucose-stimulated insulin secretion and
more-efficient proinsulin processing. The question re-
mains whether other polymorphisms, within or outside
the CAPN10 gene, act in concert with these identified
alleles to enhance disease predisposition (see the dis-
cussion above of the findings of Evans et al. [2001]).
Because we believe the loci that influence type 2 diabetes
susceptibility in the Samoans may be different from
those in other populations, we plan to first complete
our genomewide scan for such loci and then, on the
basis of our results, conduct further fine mapping and
detailed case-control studies in the indicated regions.
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